Drug intelligence / Profile preview

interferon gamma-1a

Development stage
Preclinical
Lead developer
Daiichi Sankyo
Modality
Cytokines & Interferons → Recombinant Proteins and Enzymes
Administration
Subcutaneous, Intravenous, Intramuscular
01

Overview

Interferon gamma-1a is a recombinant form of interferon gamma, a type II cytokine. Interferon gamma is a crucial cytokine involved in both innate and adaptive immunity, playing a significant role in antiviral, immunomodulatory, and antiproliferative activities. It functions by binding to the interferon-gamma receptor (IFNGR) on target cells, which then activates the JAK-STAT signaling pathway. This activation leads to various cellular effects, including the stimulation of innate immune cell development, recruitment, and activation, enhancement of effector T cell functions, activation of macrophages, increased antigen presentation, and direct suppression of tumor cell proliferation and promotion of apoptosis. In research settings, interferon gamma-1a has been shown to increase the antitumor activity of mitomycin C against human colon cancer cells, partly by increasing the intracellular uptake of mitomycin C.

Other names
interferon gammaIFNGimmune interferoninterferon type II
02

Targets

IFNGR1 (Interferon gamma receptor 1)

Beyond the preview

Go deeper on interferon gamma-1a.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on interferon gamma-1a.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call